Genic Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 07:37 am
Share
Genic Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 8.51 million compared to KRW 11.94 million a year ago. Net income was KRW 1,806.82 million compared to net loss of KRW 839.88 million a year ago. Basic earnings per share from continuing operations was KRW 264 compared to basic loss per share from continuing operations of KRW 105 a year ago. Basic earnings per share was KRW 264 compared to basic loss per share of KRW 122 a year ago.
For the nine months, sales was KRW 57.55 million compared to KRW 115.73 million a year ago. Net loss was KRW 859.33 million compared to KRW 1,469 million a year ago. Basic loss per share from continuing operations was KRW 125 compared to KRW 195 a year ago. Diluted loss per share from continuing operations was KRW 125. Basic loss per share was KRW 125 compared to KRW 213 a year ago. Diluted loss per share was KRW 125.
GENIC Co., Ltd is a Korea-based company engaged in the manufacture of cosmetic products. The Companyâs products consist of gel masks, essence masks, gel eye patches, self-heating masks, cleaners, basics and other skin care products, makeup products, hair care products, perfumes, as well as men cosmetics, body care products and manicures. The Company markets its products under the brand names of Cel-Derma, Lasante, Puretree and others. The Company distributes its products within domestic market and to overseas markets.
GENIC CO., LTD. 
